RAMSAY GENERALE DE SANTE SA Pharmaceuticals, Biotechnology & Life Sciences

$0.007 (0%)

High $0.01	Low $0.01	Trades 6	Turnover $9,683	Volume 1,383,303
30 June 2023 at 3:17pm

If you were already registered, log in here.

Short Interest

ASIC data, 6 Feb 2020

% Shorted

0.02%

Most Shorted Rank

486th

of 711 shorted ASX stocks

Peak Short

0.02%

Feb 2020

Days to Cover

0.1

at 50d avg vol

View full short position history →

	Subject
	RGS RGS Ann: Ceasing to be a substantial holder
	1 (current) 2 3
	RGS RGS Ann: Change in substantial holding
	RGS RGS Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RGS RGS Ann: Merger with Cambium
	RGS RGS Ann: Half Yearly Report and Accounts
	RGS RGS Ann: Regeneus agrees to settle $2m loan
	RGS RGS Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RGS RGS Ann: Notice of Termination of Kyocera Licence
	RGS RGS Ann: Trading Halt
	RGS RGS Ann: Regeneus receives $1.1 million R&D Tax Incentive Refund
	RGS RGS Ann: Change of Auditor
	RGS RGS Ann: Results of Annual General Meeting
	RGS RGS Ann: Chairman's Address and CEO presentation
	RGS RGS Ann: Letter to Shareholders - AGM
	RGS RGS Ann: Notice of Annual General Meeting/Proxy Form
	RGS RGS Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RGS RGS Ann: Date of AGM
	RGS RGS Ann: Appendix 4G and Corporate Governance Statement
	RGS RGS Ann: Preliminary Final Report
	RGS RGS Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RGS RGS Ann: Notification of cessation of securities - RGS
	RGS RGS Ann: Change of Director's Interest Notice
	RGS RGS Ann: Regeneus CEO cements support
	RGS RGS Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RGS RGS Ann: Notification of cessation of securities - RGS
	RGS RGS Ann: Final Director's Interest Notice
	RGS RGS Ann: Director Appointment/Resignation
	RGS RGS Ann: Half Yearly Report and Accounts
	RGS RGS Ann: Grant of ASX Waiver
	RGS RGS Ann: Notification of cessation of securities - RGS
	RGS RGS Ann: Lapse of Unlisted Share Options
	RGS RGS Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RGS RGS Ann: Appointment of Board Advisor
	RGS RGS Ann: Regeneus Market Update
	RGS RGS Ann: Results of Annual General Meeting
	RGS RGS Ann: Chairman's Address to Shareholders
	RGS RGS Ann: Supplementary Announcement - Appendix 4C
	RGS RGS Ann: Investor Update Webcast - November 2021
	RGS RGS Ann: Amendment to Institutional Placement
	RGS RGS Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	RGS RGS Ann: Regeneus Corporate Presentation (October 2021)
	RGS RGS Ann: Revised Securities Trading Policy
	RGS RGS Ann: Appendix 4G and Corporate Governance Statement
	RGS RGS Ann: Annual Report 2021
	RGS RGS Ann: Regeneus Company Update Investor Webcast Presentation
	RGS RGS Ann: Virtual Annual General Meeting Online Guide
	RGS RGS Ann: Notice of Annual General Meeting / Proxy / Question Form
	RGS RGS Ann: Application for quotation of securities - RGS
	RGS RGS Ann: Cleansing Statement
	RGS RGS Ann: Revised Date of AGM

If you were already registered, log in here.

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

Upcoming Floats (8)

MATRIX CRITICAL MINERALS LIMITED

MTX

SUPER MINERALS LTD

S88

MAVERICK URANIUM LIMITED

MAV

Fitgenes

ATW $7.5m raise

RIO DE ORO CORP LTD

RDO $30m raise

Adbri Ltd

ABC $5m raise

RAMSAY GENERALE DE SANTE SA

RGS

Gratifii

MBM

Top

End of Day Prices

Date	Close	Volume	Change
29-Apr	$0.01	0	0.00 (0.00%)
26-Apr	$0.01	0	0.00 (0.00%)
24-Apr	$0.01	118,641	+0.00 (12.50%)
23-Apr	$0.01	0	0.00 (0.00%)
22-Apr	$0.01	50,000	0.00 (0.00%)
19-Apr	$0.01	200,000	0.00 (11.11%)
18-Apr	$0.01	0	0.00 (0.00%)
17-Apr	$0.01	0	0.00 (0.00%)
16-Apr	$0.01	680,975	+0.00 (12.50%)
15-Apr	$0.01	2,433,855	0.00 (20.00%)
12-Apr	$0.01	755,915	0.00 (23.08%)
11-Apr	$0.01	1,767,281	0.00 (7.14%)
10-Apr	$0.01	459,764	+0.00 (16.67%)
09-Apr	$0.01	4,275,678	+0.00 (33.33%)
08-Apr	$0.01	1,683,175	0.00 (30.77%)
4 up, 5 down, and 6 flat days

Market Cap (29-Apr) TBC	Close (30-Jun) $0.007 0 (0%)	Volume (30-Jun) 1,383,303	Shortsold (6-Feb) 60,198 (0.02%) (486th)
52w High -	52w Low -	P/E -	EPS -

RAMSAY GENERALE DE SANTE SA Pharmaceuticals, Biotechnology & Life Sciences

Short Interest

Followers

Prices

Announcements

Similar Companies

Upcoming Floats (8)

End of Day Prices

RGS RAMSAY GENERALE DE SANTE SA Pharmaceuticals, Biotechnology & Life Sciences

Short Interest

Followers

Prices

Announcements

Similar Companies

Upcoming Floats (8)

End of Day Prices

RAMSAY GENERALE DE SANTE SA Pharmaceuticals, Biotechnology & Life Sciences